Helicobacter pylori infection, insulin resistance and nonalcoholic fatty liver disease

Med Hypotheses. 2014 Jun;82(6):795. doi: 10.1016/j.mehy.2014.03.003. Epub 2014 Mar 14.

Authors

Stergios A Polyzos¹, Jannis Kountouras², Christos Zavos², Georgia Deretzi²

Affiliations

¹ Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece. Electronic address: stergios@endo.gr.
² Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece.

PMID: 24685365
DOI: 10.1016/j.mehy.2014.03.003

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Fatty Liver / drug therapy*
Helicobacter Infections / drug therapy*
Helicobacter pylori*
Humans
Insulin Resistance / physiology*
Male
Metabolome / drug effects*

Substances

Anti-Bacterial Agents